Concerns Over Hair Loss Drug’s Mental Health Risks
Recent discussions have emerged regarding the mental health implications of finasteride, a medication commonly prescribed for male pattern baldness. Some studies indicate that this popular hair loss treatment could potentially heighten the risk of suicide among those taking it.
A comprehensive review by Professor Mayer Brezis from the Hebrew University of Jerusalem, shared in the Journal of Clinical Psychiatry, suggests there’s substantial evidence linking the drug to risks of depression, anxiety, and suicidal tendencies. Brezis points out that awareness of these serious side effects has lagged, with some reports dating back over 20 years.
Concerns aren’t new; various studies have indicated a troubling correlation between finasteride and mental health issues. Notably, from 2017 to 2023, several independent analyses revealed significant increases in depression and anxiety among users.
“We’ve been slow to recognize how severe these neuropsychiatric effects can be,” Brezis states, highlighting that many have suffered without knowing the potential ramifications of the drug. He further emphasizes that, tragically, some individuals may have taken their lives as a result of ongoing psychological distress related to finasteride.
Moreover, it’s reported that users can experience lasting symptoms, including insomnia and cognitive difficulties, even after stopping the medication. Brezis insists that as evidence mounts, it’s essential for regulators to enforce stricter requirements for ongoing evaluations of medications like finasteride.
The FDA acknowledged the potential for depression as a side effect in 2011, and more recently, noted increases in suicide rates associated with the drug. However, Brezis argues that reported figures are likely much lower than the actual impact.
In light of these findings, he urges both patients and physicians to reconsider the use of finasteride. “I suggest avoiding this medication,” he advises, cautioning against the risks linked to anxiety, depression, and other troubling side effects, which may persist after treatment has ended.
Finasteride, developed by Merck, is still widely used today under various brand names. Organon, which produces Propecia and Proscar, has defended the medication’s safety and efficacy, noting that it undergoes rigorous review even years after release.
The U.S. Department of Health and Human Services has also reminded patients to discuss potential risks with healthcare providers before using any medication, emphasizing the importance of informed consent.
